Sumatriptan Tablet
Product Images NDC 68788-6778

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 68788-6778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

A line chart showing estimated probability of response over time in minutes from initial dose. The chart compares placebo with three dose levels (25 mg, 50 mg, 100 mg) of Sumatriptan, illustrating increasing response probabilities with higher doses and longer times post-dose.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)

A line graph showing the estimated probability of headache remediation or rescue over time in hours from the initial dose. The graph compares placebo, 25 mg, 50 mg, and 100 mg doses of Sumatriptan, illustrating different probabilities of relief or rescue treatment within a 24-hour period.*

FDA Label Image

Sumatriptan Succinate Tablets 100mg (Sumatriptan Fig5)

Sumatriptan Succinate Tablets 100 mg oral tablet label by Preferred Pharmaceuticals, Inc. The label indicates the product is a generic for Imitrex, contains 100 mg sumatriptan succinate per tablet, and includes manufacturer details for Aurobindo Pharma Limited. The label includes dosage instructions, warnings, and regulatory caution statements.*

FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical structure of Sumatriptan Succinate, the active ingredient in Sumatriptan 100 mg oral tablets by Preferred Pharmaceuticals, Inc. The structure shows the molecular arrangement including sulfonamide, indole, and succinate moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.